Newsletter Signup | Join Community
Research suggests some patients with CML can safely discontinue TKI therapy - NCCN guidelines published.
Drug resistance can occur when CML no longer responds to a TKI and there are a number of possible causes
Tibsovo approved for treatment of newly diagnosed and relapsed Acute Myeloid Leukemia with an IGH1 mutation
Bosulif superior to early generation TKI's for treatment of Chronic Myelogenous Leukemia
Gazyva improves survival and delays the CLL progression.
Blincyto prolongs survival in relapsed/refractory adult ALL and can be used in combination with other medications.
Stay Current With Leukemia Treatment Advances & Connect with Others
FDA Approves Precision Medicine Enasidenib as new Targeted Treatment for individuals with AML and IDH2 genetic mutation
FDA Approves Venclexta, Daurismo, and Xospata Precision Cancer Medicines for Treatment of Acute Myeloid Leukemia
Trisonex (arsenic) has become an effective and standard treatment for all phases of acute promyelocytic leukemia.
considering CAR T for ALL - anyone been through it yet?
looking for others to share their experience with stem cell transplant for leukemia.